Immuno-virological response and clinical outcome in naive elderly patients treated with antiretroviral therapy (HAART)

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2318

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Immuno-virological response and clinical outcome in naive elderly patients treated with antiretroviral therapy (HAART) ; volume:10 ; number:1 ; day:19 ; month:5 ; year:2010 ; pages:1 ; date:8.2010
BMC geriatrics ; 10, Heft 1 (19.5.2010), 1, 8.2010

Creator: Bisicchia, F.

Contributor: Celesia, B M.
La Rosa, R.
Mavilla, S.
Gussio, M.
Mughini, M T.
Palermo, F.
Russo, R.
SpringerLink (Online service)

DOI: 10.1186/1471-2318-10-S1-A87

URN: urn:nbn:de:1111-2016021822488

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:34 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Bisicchia, F.
Celesia, B M.
La Rosa, R.
Mavilla, S.
Gussio, M.
Mughini, M T.
Palermo, F.
Russo, R.
SpringerLink (Online service)

Other Objects (12)

HAART in HIV+ naive elderly patients: immuno-virological response and clinical outcome

Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome

Virological treatment outcome under HAART: does sex matter?

Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART

Tolerability of antiretroviral therapy (HAART) in elderly age

The prognosis of patients with dissociated virological and immunological responses to HAART

Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia

Long-term virological outcome in children receiving first-line antiretroviral therapy

Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART

Is HAART based on newest active antiretroviral drugs influenced by GSS?

Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression

Prevalence of cytopenias in both HAART and HAART naïve HIV infected adult patients in Ethiopia: a cross sectional study

HAART in HIV+ naive elderly patients: immuno-virological response and clinical outcome

Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome

Virological treatment outcome under HAART: does sex matter?

Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART

Tolerability of antiretroviral therapy (HAART) in elderly age

The prognosis of patients with dissociated virological and immunological responses to HAART

Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia

Long-term virological outcome in children receiving first-line antiretroviral therapy

Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART

Is HAART based on newest active antiretroviral drugs influenced by GSS?

Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression

Prevalence of cytopenias in both HAART and HAART naïve HIV infected adult patients in Ethiopia: a cross sectional study

HAART in HIV+ naive elderly patients: immuno-virological response and clinical outcome

Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome

Virological treatment outcome under HAART: does sex matter?

Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART

Tolerability of antiretroviral therapy (HAART) in elderly age

The prognosis of patients with dissociated virological and immunological responses to HAART

Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia

Long-term virological outcome in children receiving first-line antiretroviral therapy

Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART

Is HAART based on newest active antiretroviral drugs influenced by GSS?

Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression

Prevalence of cytopenias in both HAART and HAART naïve HIV infected adult patients in Ethiopia: a cross sectional study

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Immuno-virological response and clinical outcome in naive elderly patients treated with antiretroviral therapy (HAART)

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

HAART in HIV+ naive elderly patients: immuno-virological response and clinical outcome

Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome

Virological treatment outcome under HAART: does sex matter?

Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART

Tolerability of antiretroviral therapy (HAART) in elderly age

The prognosis of patients with dissociated virological and immunological responses to HAART

Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia

Long-term virological outcome in children receiving first-line antiretroviral therapy

Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART

Is HAART based on newest active antiretroviral drugs influenced by GSS?

Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression

Prevalence of cytopenias in both HAART and HAART naïve HIV infected adult patients in Ethiopia: a cross sectional study

HAART in HIV+ naive elderly patients: immuno-virological response and clinical outcome

Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome

Virological treatment outcome under HAART: does sex matter?

Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART

Tolerability of antiretroviral therapy (HAART) in elderly age

The prognosis of patients with dissociated virological and immunological responses to HAART

Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia

Long-term virological outcome in children receiving first-line antiretroviral therapy

Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART

Is HAART based on newest active antiretroviral drugs influenced by GSS?

Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression

Prevalence of cytopenias in both HAART and HAART naïve HIV infected adult patients in Ethiopia: a cross sectional study

HAART in HIV+ naive elderly patients: immuno-virological response and clinical outcome

Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome

Virological treatment outcome under HAART: does sex matter?

Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART

Tolerability of antiretroviral therapy (HAART) in elderly age

The prognosis of patients with dissociated virological and immunological responses to HAART

Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia

Long-term virological outcome in children receiving first-line antiretroviral therapy

Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART

Is HAART based on newest active antiretroviral drugs influenced by GSS?

Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression

Prevalence of cytopenias in both HAART and HAART naïve HIV infected adult patients in Ethiopia: a cross sectional study

Related objects

Reset password